Quantification of Celiac Disease Gluten Epitopes

Scientists have published a novel method in the Journal of Chromatography A to detect multiple celiac disease-epitopes in wheat extracts simultaneously using liquid chromatography–multiple reaction monitoring mass spectrometry (LC–MRM–MS).¹

Celiac disease is caused by an immune response in the small intestine from eating gluten proteins. An enzyme-linked immunosorbent assay (ELISA) is the standard testing method for food, but this can be inaccurate and does not differentiate between gluten proteins. Lead author Hetty van den Broeck told The Column: “This newly developed method based on mass spectrometry quantifies specifically celiac disease stimulating epitopes. This is not possible by ELISA, which detects gluten proteins in general by using a monoclonal antibody. Mass spectrometry allows specific detection and quantification of multiple CD-epitopes at the same time. This is necessary because of the complex genome of bread wheat and the many different CD-epitopes to which CD-patients can respond differentially.”

In the current study, gluten extracts were prepared from wheat and extracted prior to LC–MRM–MS analysis. The authors developed the method to detect peptides known to induce the strongest immune response, as well as peptides with amino acid substitutions that make  them harmless. The method was able to quantify different peptide isoforms, showing that a modern wheat variety, Toronto, contained the highest level of CD immunogenic peptides.

The team are continuing their work to test and select reduced immunogenic wheat varieties, van den Broeck told The Column. She said: “We are also working on the development of screening body fluids from CD-patients for the presence of these epitopes or other specific peptide biomarkers for CD.”- B.D.

Reference
1. H.C. van den Broeck et al., J. Chromatogr. A1391, 60–71 (2015).

This article was featured in LCGC's digital magazine, The Column. Click here to view the full issue >>